David M Feldser

14PUBLICATIONS

54CO-AUTHORS

Haematological tumoursPredictive and prognostic markersMolecular targetsLiquid biopsiesCarbon capture engineering (excl. sequestration)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Oct 14, 2026

Antagonistic roles of histone H3 lysine methyltransferases dictate tumor immune surveillance.

|Jun 15, 2026

Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancer.

|Jun 12, 2025

The H3 K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer.

Amy C Gladstein, Carson D Poltorack, Akino Mercy Charles Solomon

|Sep 20, 2023

Metastatic Competency and Tumor Spheroid Formation Are Independent Cell States Governed by RB in Lung Adenocarcinoma.

Nelson F Freeburg, Nia Peterson, Dain A Ruiz

|Jul 21, 2023

p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism.

Jonuelle Acosta, Qinglan Li, Nelson F Freeburg

|Mar 10, 2023

Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling.

David M Walter, Amy C Gladstein, Katherine R Doerig

Pageof 3

Frequent Collaborators

Amy C Gladstein

Monte M Winslow

Keren M Adler

Simone Sidoli

Nelson F Freeburg

Valerie M Irizarry-Negron

Min K Tsai

Dain A Ruiz

Sarah E Pierce

David M Walter

Frequent Collaborators

Amy C Gladstein

Monte M Winslow

Keren M Adler

Simone Sidoli